Description

Lidaza-Biofarma Powder for Solution for Injections 64 IU №10 Vial

Ingredients:

Lidaza-Biofarma contains the active ingredient hyaluronidase, which helps in the breakdown of hyaluronic acid, a substance found in the body’s tissues.

Dosage:

It is important to follow the prescribed dosage by a healthcare professional. Typically, Lidaza-Biofarma is administered as a solution for injections with a strength of 64 IU.

Indications:

Lidaza-Biofarma is indicated for the treatment of various conditions where improved drug absorption and dispersion are required, such as edema, inflammation, and scar tissue.

Contraindications:

Patients with a known hypersensitivity to hyaluronidase or any other component of the formulation should avoid using Lidaza-Biofarma.

Directions:

The solution for injections should be administered as directed by a healthcare provider. It is usually injected into the affected area to facilitate the dispersion of other medications or to reduce swelling.

Scientific Evidence:

Studies have shown that hyaluronidase, the active ingredient in Lidaza-Biofarma, can enhance the absorption and effectiveness of various drugs when used in combination. This enzymatic action helps in breaking down barriers in tissues, allowing for better drug penetration.

Additional Information:

Lidaza-Biofarma has been widely used in clinical practice to improve the therapeutic outcomes of various medications. Its ability to enhance drug dispersion and absorption makes it a valuable tool in managing conditions that require localized treatment.

Furthermore, research has indicated that hyaluronidase can also play a role in reducing tissue fibrosis and promoting wound healing by breaking down excess extracellular matrix components. This dual action of Lidaza-Biofarma highlights its versatility in clinical applications.